WESTLAKE CHEMICAL PARTNERS LP |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.06 USD | +0.36% |
|
+1.33% | +1.71% |
| Feb. 20 | Transcript : Westlake Chemical Partners LP, Q4 2023 Earnings Call, Feb 20, 2024 | |
| Feb. 20 | Earnings Flash (WLKP) WESTLAKE CHEMICAL PARTNERS Reports Q4 Revenue $297.3M | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- This company will be of major interest to investors in search of a high dividend stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +1.71% | 774M | - | - | |
| +5.14% | 103B | A- | ||
| -5.63% | 63.04B | A- | ||
| +39.52% | 39.49B | B | ||
| +12.91% | 36.62B | B | ||
| +7.10% | 32.44B | A- | ||
| +7.09% | 19.07B | B- | ||
| +12.86% | 16.63B | C+ | ||
| +16.93% | 15.14B | B- | ||
| +7.73% | 14.73B | B |
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
-
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- WLKP Stock
- Ratings Westlake Chemical Partners LP
